BaseClear

BaseClear is a biotechnology startup that focuses on offering genomics expertise and consultancy to accelerate the understanding and use of microorganisms. With a mission to tap into the vast potential of microbes to address issues such as antibiotic resistance, personal disease, poor crop yields, and problems caused by global warming, the company leverages the latest DNA technologies to uncover the interactions between microbes and their hosts and environment.

Founded in 1993, BaseClear has established itself as a pioneer in the microbial genomics revolution. The company has become a preferred partner for numerous leading brands in various industries, including human health, personal care, and animal nutrition, not only in The Netherlands and Europe but also beyond. BaseClear supports its clients in enhancing their processes and products, obtaining approval, and validating claims.

Despite the absence of specific information regarding the headquarter, last investment, or last investment investors, BaseClear's reputation and extensive experience in the biotechnology sector make it a noteworthy contender for potential venture capital opportunities. The company's expertise and impact across a broad spectrum of industries position it as a promising investment option for venture capitalists seeking to capitalize on the growing importance of genomics and microbial research in addressing global challenges.